Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
HPMC Capsules Market size was valued at US$ 359.2 million in 2023 and is poised to grow US$ 660.8 million by 2030, at a CAGR of 9.1% during forecast period 2023-2030. Furthermore, these are also considered to be safe for normal human consumption and is commonly used as an option instead of gelatin because of its vegetarian source and its physical appearance to gelatin. Moreover, this is also used as raw material for coatings with moderate strength, moderate moisture, and oxygen barrier properties, elasticity, transparency, and resistance to oil and fat. This can also be used as a tablet binder and as a tablet matrix for extended release. Additionally, HPMC products are Kosher, Vegetarian-society and Vegan certified. The demand for HPMC capsules for oral consumption has risen considerably due to its universal use without any fillers. For instance, in 2014, around 10%-15% of the USA,s supplements and medications were launched in capsule form, compared to just 5% in 2007.
Over the years gelatin capsules were the preferred choice of capsule shells in the pharmaceutical industry and planned to remain popular, however vegetarian capsules such as Hydroxy Propyl Methyl Cellulose or HPMC capsules have started to infiltrate. Hydroxy propyl methyl cellulose (HPMC) has become a successful alternative material for two-piece capsules and is used for supplements all over the world. This report studies global HPMC capsules market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global HPMC capsules market report includes human demographics regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Study Period
2024-30Base Year
2023CAGR
9.1%Largest Market
Asia PacificFastest Growing Market
North America
Pharmaceutical industries have already started using halal-certified ingredients and manufacturing methods to cash in on the high buying power of Muslims in Europe. However, Muslims in Europe are very less than in other parts of the world, purchasing power is much greater than that of members of the community in Southeast Asia, the Middle East and Sub-Saharan Africa, with Turkey, Russia and France all figuring in the top 10 markets. In Asia Pacific countries, manufacturers have started manufacturing vegetarian capsules on demand for the products in the Asia Pacific countries.
Report Benchmarks |
Details |
Report Study Period |
2024-30 |
Market Size in 2023 |
US$ 359.2 million |
Market Size in 2030 |
US$ 660.8 million |
Market CAGR |
9.1% |
By Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
The HPMC capsules market is projected to expand at a CAGR of 9.1% during the forecast period
Lonza (Capsugel), Qingdao Capsule, Sunil Healthcare, ACG Associated Capsules, CapsCanada, Lefan Capsule, Qualicaps, Shanxi GS Capsule, Suheung Capsule
North America is the fastest-growing region for HPMC capsules market
1.Executive Summary |
2.Global Hpmc Capsules Market Introduction |
2.1.Global Hpmc Capsules Market - Taxonomy |
2.2.Global Hpmc Capsules Market - Definitions |
2.2.1.Type |
2.2.2.Functionality |
2.2.3.Geography |
2.2.4.Region |
3.Global Hpmc Capsules Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Hpmc Capsules Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Hpmc Capsules Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Subscription Models |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Ownership Models |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Hpmc Capsules Market By Functionality, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Clinical Functionality |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Administrative Functionality |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Financial Functionalit |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Hpmc Capsules Market By Geography, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Asia Pacific |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Middle East |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Eroupe |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Africa |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Hpmc Capsules Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Hpmc Capsules Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Subscription Models |
9.1.2.Ownership Models |
9.2. Functionality Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Clinical Functionality |
9.2.2.Administrative Functionality |
9.2.3.Financial Functionalit |
9.3. Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.North America |
9.3.2.Asia Pacific |
9.3.3.Middle East |
9.3.4.Eroupe |
9.3.5.Africa |
9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Hpmc Capsules Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Subscription Models |
10.1.2.Ownership Models |
10.2. Functionality Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Clinical Functionality |
10.2.2.Administrative Functionality |
10.2.3.Financial Functionalit |
10.3. Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.North America |
10.3.2.Asia Pacific |
10.3.3.Middle East |
10.3.4.Eroupe |
10.3.5.Africa |
10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Hpmc Capsules Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Subscription Models |
11.1.2.Ownership Models |
11.2. Functionality Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Clinical Functionality |
11.2.2.Administrative Functionality |
11.2.3.Financial Functionalit |
11.3. Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.North America |
11.3.2.Asia Pacific |
11.3.3.Middle East |
11.3.4.Eroupe |
11.3.5.Africa |
11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Hpmc Capsules Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Subscription Models |
12.1.2.Ownership Models |
12.2. Functionality Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Clinical Functionality |
12.2.2.Administrative Functionality |
12.2.3.Financial Functionalit |
12.3. Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.North America |
12.3.2.Asia Pacific |
12.3.3.Middle East |
12.3.4.Eroupe |
12.3.5.Africa |
12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Hpmc Capsules Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Subscription Models |
13.1.2.Ownership Models |
13.2. Functionality Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Clinical Functionality |
13.2.2.Administrative Functionality |
13.2.3.Financial Functionalit |
13.3. Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.North America |
13.3.2.Asia Pacific |
13.3.3.Middle East |
13.3.4.Eroupe |
13.3.5.Africa |
13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Lonza (Capsugel) |
14.2.2.Qingdao Capsule |
14.2.3.Sunil Healthcare |
14.2.4.ACG Associated Capsules |
14.2.5.CapsCanada |
14.2.6.Lefan Capsule |
14.2.7.Qualicaps |
14.2.8.Shanxi GS Capsule |
14.2.9.Suheung Capsule |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players